| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Maze Therapeutics, Inc. (MAZE) has 16 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. MAZE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.47M | $113.95M | - | |
| CFO | 325.0K | $8.28M | - | |
| CEO | 100.0K | $2.55M | - | |
| Dir | 36.0K | $916.9K | - | |
| Dir | 31.1K | $792.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | Bernstein Harold62 | President, R&D &CMO | Sale+OE | 15,000 | $49.10 | $736,439.29 | -51.9% | - | - | |
| Mar 10, 2026 | Bernstein Harold62 | President, R&D &CMO | Sale+OE | 30,000 | $50.45 | $1,513,560.22 | -98.9% | - | - | |
| Jan 7, 2026 | Bernstein Harold62 | President, R&D &CMO | Sale+OE | 25,156 | $40.20 | $1,011,298.87 | -100% | -29.8% | - | |
| Jan 7, 2026 | Sohn Catherine A.55 | Director | Sale+OE | 29,413 | $39.07 | $1,149,054.36 | -100% | -29.8% | - | |
| Jan 5, 2026 | Bernstein Harold62 | President, R&D &CMO | Sale+OE | 4,844 | $40.39 | $195,667.53 | -100% | -24.9% | - | |
| Jan 2, 2026 | Bachrodt Amy60 | SVP, Finance | Sale+OE | 5,000 | $39.15 | $195,753.59 | -14.9% | -27.8% | - | |
| Dec 30, 2025 | Bachrodt Amy60 | SVP, Finance | Sale+OE | 15,000 | $40.41 | $606,173.28 | -27.5% | -27.6% | - | |
| Dec 30, 2025 | Dandekar Atul | Csbo | Sale+OE | 72,500 | $40.56 | $2,940,799.44 | -65.9% | -27.6% | - | |
| Dec 29, 2025 | Bernstein Harold62 | President, R&D &CMO | Sale+OE | 45,000 | $40.56 | $1,825,354.84 | -72.3% | -28.5% | - | |
| Sep 15, 2025 | Scheller Richard H90 | Director | Sell | 20,744 | $22.37 | $464,034.98 | -100% | +70.8% | - |